Stock FEMY FEMASYS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Femasys Inc.

Equities

FEMY

US31447E1055

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 21:30:00 03/05/2024 BST 		5-day change 1st Jan Change
1.29 USD +4.45% Intraday chart for Femasys Inc. +1.57% +32.31%
04-01 HC Wainwright Adjusts Femasys' Price Target to $12 From $10, Reiterates Buy Rating MT
03-28 Femasys Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Femasys Inc. is a biomedical company. The Company is focused on addressing unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. The Company also developed a technology platform, namely FemEMB for tissue sampling intended to be marketed alongside its other women-specific medical products in the physician’s office setting.

Number of employees: 33

Sales per Business

USD in Million2022Weight2023Weight Delta
FemVue
100.0 %
1 100.0 % 1 100.0 % -11.13%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
94.6 %
1 90.4 % 1 94.6 % -7.01%
International
5.4 %
0 9.6 % 0 5.4 % -49.90%

Managers

Managers TitleAgeSince
Kathy Lee-Sepsick FOU
 Founder 56 31/12/03
Dov Elefant DFI
 Director of Finance/CFO 56 27/02/22
James Liu CTO
 Chief Tech/Sci/R&D Officer - 11-29
Jeremy Sipos CTO
 Chief Tech/Sci/R&D Officer - 31/12/11
Christine Thomas CTO
 Chief Tech/Sci/R&D Officer 51 11/10/22
Daniel Currie COO
 Chief Operating Officer 60 31/12/03

Members of the board

Members of the board TitleAgeSince
Charlie Larsen CHM
 Chairman 72 13/10/15
Joshua Silverman BRD
 Director/Board Member 53 11-20
Kathy Lee-Sepsick FOU
 Founder 56 31/12/03
Edward Uzialko BRD
 Director/Board Member 73 31/07/05
Alistair Milnes BRD
 Director/Board Member 50 13/06/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 22,337,941 20,532,203 ( 91.92 %) 117,223 ( 0.5248 %) 91.92 %

Shareholders

NameEquities%Valuation
Edward Uzialko
5.623 %
1,217,406 5.623 % 2 M $
CM Management LLC
2.079 %
450,000 2.079 % 697 500 $
Kathy Lee-Sepsick
1.617 %
350,001 1.617 % 542 502 $
Clear Creek Financial Management LLC
1.429 %
309,274 1.429 % 479 375 $
Vanguard Group, Inc. (Subfiler)
0.7172 %
155,261 0.7172 % 240 655 $
Geode Capital Management LLC
0.6384 %
138,219 0.6384 % 214 239 $
Daniel Currie
0.4140 %
89,632 0.4140 % 138 930 $
Northern Trust Global Investments Ltd.
0.3634 %
78,670 0.3634 % 121 939 $
BlackRock Institutional Trust Co. NA
0.3198 %
69,232 0.3198 % 107 310 $
City National Bank (Los Angeles, California)
0.2445 %
52,935 0.2445 % 82 049 $

Company contact information

Femasys, Inc.

3950 Johns Creek Court Suite 100

30024, Suwanee

+

http://www.femasys.com
address Femasys Inc.(FEMY)

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Medical Equipment, Supplies & Distribution
Other Medical Equipment, Supplies & Distribution

Sales per region

Ratings for Femasys Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.29 USD
Average target price
9.75 USD
Spread / Average Target
+655.81%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
FEMASYS INC. Stock Femasys Inc.
+32.31% 28.51M
ABBOTT LABORATORIES Stock Abbott Laboratories
-3.79% 184B
MEDTRONIC PLC Stock Medtronic plc
-0.84% 108B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.75% 67.8B
DEXCOM, INC. Stock DexCom, Inc.
+3.45% 51.05B
CENCORA, INC. Stock Cencora, Inc.
+9.04% 44.67B
HOYA CORPORATION Stock Hoya Corporation
+3.40% 41.78B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+3.21% 26.78B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+3.66% 26.59B
TERUMO CORPORATION Stock Terumo Corporation
+15.23% 25.86B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. FEMY Stock
  4. Company Femasys Inc.